Multicellular tumor spheroids of LNCaP-Luc prostate cancer cells as in vitro screening models for cytotoxic drug

被引:0
作者
Jouberton, Elodie [1 ]
Voissiere, Aurelien [2 ]
Penault-Llorca, Frederique [1 ]
Cachin, Florent [1 ]
Miot-Noirault, Elisabeth [2 ]
机构
[1] Clermont Auvergne Univ, Ctr Jean Perrin, INSERM, U1240 Mol Imaging & Theranost Strategies, F-63000 Clermont Ferrand, France
[2] Clermont Auvergne Univ, INSERM, U1240 Mol Imaging & Theranost Strategies, F-63000 Clermont Ferrand, France
关键词
Prostate cancer; spheroid; hypoxia; HYPOXIA-ACTIVATED PRODRUGS; SOLID TUMORS; OXYGENATION; RESISTANCE; MICROENVIRONMENT; EXPRESSION; THERAPY; CULTURE; IMPACT; PH;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An increasing number of studies concerning solid cancers, including prostate cancer, are tending to demonstrate the predominant role of the interactions of tumor cells with their microenvironment, and underlining the relevance of therapeutic approaches co-targeting these two components. Artificial in vitro 3D culture models, such as spheroids, are therefore being designed to allow intercellular interactions between tumor cells and the matrix, under hypoxic conditions mimicking a microtumor. This project aims to develop and characterize a multicellular tumor spheroid (MCTS) model of human prostate cancer cells expressing PSMA, for in vitro drug screening. To this end, 1,000 cells/well were seeded in 100 mu l of culture medium with 0.5% of methylcellulose in 96-well, non-adherent, V-shaped bottom plates. Bioluminescent imaging of the spheroids enabled the measurement of spheroid growth. From Day 7 of growth, immunofluorescence studies showed cellular proliferation (Ki-67), mainly located in the periphery of the spheroid section, associated with the formation of an apoptotic core (TUNEL). Scanning electron microscopy and fluorescent imaging (Lox-1 probe) showed the presence of an extracellular matrix and the installation of an oxygen gradient leading to the formation of a hypoxic area during growth. This hypoxia was correlated with increased VEGF excretion. Drug sensitivity was assessed on 2D and 3D cultures. The LNCaP-Luc spheroids are more resistant to docetaxel and TH-302, a hypoxia-activated prodrug, compared with cells grown in a monolayer. For docetaxel, this resistance increased with the spheroid growth stage, whereas the activity of TH-302 was potentiated by the hypoxic environment. In conclusion, the development of LNCaP-Luc cell MCTS provides a simple model mimicking a microtumor; it appears to be particularly well-suited to the validation of new therapeutic approaches targeting proliferation and the microenvironment.
引用
收藏
页码:1116 / 1128
页数:13
相关论文
共 50 条
[1]   Microscopic images of intraspheroidal pH by 1H magnetic resonance chemical shift imaging of pH sensitive indicators [J].
Alvarez-Pérez, J ;
Ballesteros, P ;
Cerdán, S .
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE, 2005, 18 (06) :293-301
[2]   Molecular Pathways: Hypoxia-Activated Prodrugs in Cancer Therapy [J].
Baran, Natalia ;
Konopleva, Marina .
CLINICAL CANCER RESEARCH, 2017, 23 (10) :2382-2390
[3]   Randomized Phase II Trial of Gemcitabine Plus TH-302 Versus Gemcitabine in Patients With Advanced Pancreatic Cancer [J].
Borad, Mitesh J. ;
Reddy, Shantan G. ;
Bahary, Nathan ;
Uronis, Hope E. ;
Sigal, Darren ;
Cohn, Allen L. ;
Schelman, William R. ;
Stephenson, Joe, Jr. ;
Chiorean, E. Gabriela ;
Rosen, Peter J. ;
Ulrich, Brian ;
Dragovich, Tomislav ;
Del Prete, Salvatore A. ;
Rarick, Mark ;
Eng, Clarence ;
Kroll, Stew ;
Ryan, David P. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) :1475-1481
[4]   Hypoxia and cancer [J].
Brahimi-Horn, M. Christiane ;
Chiche, Johanna ;
Pouyssegur, Jacques .
JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (12) :1301-1307
[5]   Human tissues in a dish: The research and ethical implications of organoid technology [J].
Bredenoord, Annelien L. ;
Clevers, Hans ;
Knoblich, Juergen A. .
SCIENCE, 2017, 355 (6322)
[6]   Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma [J].
Brenner, Andrew J. ;
Floyd, John ;
Fichtel, Lisa ;
Michalek, Joel ;
Kanakia, Kunal P. ;
Huang, Shiliang ;
Reardon, David ;
Wen, Patrick Y. ;
Lee, Eudocia Quant .
SCIENTIFIC REPORTS, 2021, 11 (01)
[7]   PRETREATMENT OXYGENATION PROFILES OF HUMAN SOFT-TISSUE SARCOMAS [J].
BRIZEL, DM ;
ROSNER, GL ;
HARRELSON, J ;
PROSNITZ, LR ;
DEWHIRST, MW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (03) :635-642
[8]   3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer [J].
Chambers, Karen F. ;
Mosaad, Eman M. O. ;
Russell, Pamela J. ;
Clements, Judith A. ;
Doran, Michael R. .
PLOS ONE, 2014, 9 (11)
[9]  
Comerford KM, 2002, CANCER RES, V62, P3387
[10]   Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma [J].
Courtney, Kevin D. ;
Infante, Jeffrey R. ;
Lam, Elaine T. ;
Figlin, Robert A. ;
Rini, Brian I. ;
Brugarolas, James ;
Zojwalla, Naseem J. ;
Lowe, Ann M. ;
Wang, Keshi ;
Wallace, Eli M. ;
Josey, John A. ;
Choueiri, Toni K. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (09) :867-+